About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT00754507

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.

To determine the effects of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized on atorvastatin therapy for at least 4 weeks.

Lead sponsor: Daiichi Sankyo•13 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Daiichi Sankyo

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male or female \> or greater than 18 years of age
•On a stable dose of atorvastatin
•LDL-C \> or = to 115 mg/dL and \< or = to 250 mg/dL
•TG \< or = to 300 mg/dL
•Women are not pregnant or breast-feeding or planning to become pregnant
•Women of child-bearing potential had a hysterectomy or tubal-ligation, or
•women were post menopausal, or
•women practiced an acceptable method of contraception as specified in the protocol

Exclusion Criteria

•BMI \> 40 kg/m2
•History of allergic or toxic reaction to colesevelam HCl
•History of swallowing disorders
•Any serious disorder that could impact the conduct of the study
•History of drug or alcohol abuse

Related studies

RECRUITINGPhase 3

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

NCT07473960 · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Pharmacogenomic Informed Statin Prescribing

NCT06568601 · Hypercholesterolemia

Causes and Natural History of Dyslipidemias

NCT00353782 · Hypercholesterolemia, Atherosclerosis

RECRUITINGPhase 2

A Dose-exploration Study of EDP167 in HoFH

NCT07489209 · Homozygous Familial Hypercholesterolemia (HoFH)

RECRUITINGPhase 3

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

NCT07037771 · Homozygous Familial Hypercholesterolemia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 3, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment65

Start dateNov 2002

Last updatedApr 3, 2015

Condition

Hypercholesterolemia

Locations shown

Los Angeles, California

Castle Rock, Colorado

Jacksonville, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 3, 2015Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions